Vaxcell-Bio Therapeutics Co., Ltd.
323990.KQFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
1
Cost of Revenue
1
Gross Profit
0
Gross Margin
19.2%
Operating Income
-11
Operating Margin
-791.9%
Net Income
-8
Net Margin
-559.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-7
EBITDA Margin
-470.4%
2023
12/31/2023
Revenue
0
Cost of Revenue
0
Gross Profit
0
Gross Margin
51.9%
Operating Income
-9
Operating Margin
-83855.3%
Net Income
-8
Net Margin
-74869.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-7
EBITDA Margin
-71638.6%
2022
12/31/2022
Revenue
0
Cost of Revenue
0
Gross Profit
-0
Gross Margin
N/A
Operating Income
-6
Operating Margin
N/A
Net Income
-5
Net Margin
N/A
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-5
EBITDA Margin
N/A
2021
12/31/2021
Revenue
0
Cost of Revenue
0
Gross Profit
-0
Gross Margin
N/A
Operating Income
-4
Operating Margin
N/A
Net Income
-4
Net Margin
N/A
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-3
EBITDA Margin
N/A
2020
12/31/2020
Revenue
0
Cost of Revenue
0
Gross Profit
-0
Gross Margin
N/A
Operating Income
-3
Operating Margin
N/A
Net Income
-3
Net Margin
N/A
EPS (Basic)
$-4387500.00
EPS (Diluted)
$-4387500.00
EBITDA
-3
EBITDA Margin
N/A